Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| injection, powder, lyophilized, for solution | 3 |
| Route | NDCs |
|---|---|
| intravenous | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| onyx pharmaceuticals, inc. | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| KYPROLIS | carfilzomib | injection, powder, lyophilized, for solution, intravenous | 76075-101NDA |
| KYPROLIS | carfilzomib | injection, powder, lyophilized, for solution, intravenous | 76075-102NDA |
| KYPROLIS | carfilzomib | injection, powder, lyophilized, for solution, intravenous | 76075-103NDA |
Enquiry
Common questions
- Is Onyx Pharmaceuticals, Inc. FDA approved?
- Onyx Pharmaceuticals, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Onyx Pharmaceuticals, Inc. make?
- 3 products are listed under Onyx Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.